The Link Between Trauma and Alcohol Use Disorder: Utilizing Medications as a Way Forward

The Link Between Trauma and Alcohol Use Disorder: Utilizing Medications as a Way Forward

Host: National Council for Mental Wellbeing
Recorded: January 14, 2025
Enduring Training

Overview

Trauma and adverse childhood experiences (ACEs) are associated with numerous negative health outcomes, including alcohol use disorder (AUD) and other substance use disorders. Nearly two-thirds of U.S. adults have experienced at least one ACE in their lifetime, and one-sixth have experienced four or more. There is a dose–response relationship between the number of ACEs experienced and the risk for AUD and other negative health outcomes. People who have experienced four or more ACES are two to five times more likely to develop negative health outcomes, including AUD. While 28.1 million U.S. adults had AUD in 2023, less than 10% of those people received treatment, and only 2% received a medication for AUD (MAUD).

This case-based discussion explores relationship between trauma and AUD, treatment options and the benefits of using MAUD. The discussion is lead by two experts in the field who have extensive experience in trauma, mental health, substance use, and expertise in reducing the risks associated with alcohol use. 

This course is eligible for 1.5 NBCC Contact Hour and 1 NAADAC CE. 

The target audience for this intermediate level activity includes: Prescribers of all types

Learning Objectives

Upon completion, learners will be able to:

1. Define the relationship between the prevalence of trauma and alcohol use disorder.
2. Outline protocols for screening, diagnosing and treating trauma and alcohol use disorder.
3. Describe the benefits of using medications for alcohol use disorder (MAUD) as a treatment for people experiencing trauma and AUD.

Open Registration: 08/30/2027

Close Access Date: 09/30/2027

Instructions

1. Click on the Contents tab to begin this activity.  
2. Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window. 
3. Click Claim Certificate of Completion to view/print certificate.  

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.

Accreditation & Credit Designation Statements

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

National Board for Certified Counselors ACEP 

This activity offers 1.5 NBCC Contact Hour(s).

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

NAADAC, The Association for Addiction Professionals

This course has been approved by the American Society of Addiction Medicine (ASAM) as a NAADAC Approved Education Provider, for 1.5 CE(s). NAADAC Provider #295, the American Society of Addiction Medicine (ASAM) is responsible for all aspects of its programing.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-0227.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

The following planners have relevant financial relationships:

• Kevin Sevarino, MD, PhD (Advisory Committee/Planner): GlaxoSmithKline, Stockholder

All other planners, faculty, and staff have no relevant financial relationships.

All relevant financial relationships have been identified and mitigated.